Minor
ACE-232 · Metastatic Castration-Resistant Prostate Cancer
Trial sites expanded: 9 → 13 locations
Acerand Therapeutics (Hong Kong) LimitedPhase 1 NCT06801236 Registry history of NCT06801236 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 9 → 13 locations
Acerand Therapeutics (Hong Kong) LimitedPhase 1 NCT06801236 Registry history of NCT06801236 on ClinicalTrials.gov (opens the registry)
| Phase 1 | 1 |
Prostate Cancer (1)